Evidence map›Paper›PMID 32705370›Full record

ArticleAIDS and behavior2021

Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention.

Karli R Hochstatter, Wajiha Z Akhtar, Sarah Dietz, Klaren Pe-Romashko, David H Gustafson, Dhavan V Shah, Sarah Krechel, Cameron Liebert, Rebecca Miller, Nabila El-Bassel and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 4 pooled it
2.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 4 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Karli R HochstatterSocial Intervention Group, Columbia University, 1255 Amsterdam Ave, New York, NY, 10027, USA. khochsta@medicine.wisc.edu.ORCID http://orcid.org/0000-0001-6891-953X
Wajiha Z AkhtarDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Sarah DietzDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Klaren Pe-RomashkoCenter for Health Enhancement Systems Studies, Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI, USA.
David H GustafsonCenter for Health Enhancement Systems Studies, Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI, USA.
Dhavan V ShahCenter for Health Enhancement Systems Studies, Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI, USA.
Sarah KrechelVivent Health, Milwaukee, WI, USA.
Cameron LiebertVivent Health, Milwaukee, WI, USA.
Rebecca MillerDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
Nabila El-BasselSocial Intervention Group, Columbia University, 1255 Amsterdam Ave, New York, NY, 10027, USA.
Ryan P WestergaardDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.
University of Wisconsin–Madison · USMilwaukee Health Department · USColumbia University · USWisconsin Department of Health Services · US

Funding

Training Program on HIV and Substance Use in the Criminal Justice SystemT32DA037801 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Nabila El-Bassel, Lisa R Metsch · 2014 to 2026
$5.7M
Improving HIV Service Delivery for People who Inject Drugs in KazakhstanR01DA041063 · NIDA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI EL-BASSEL, NABILA, GILBERT, LOUISA · 2015 to 2019
$4.7M
The Lifespan/Brown Criminal Justice Research Program on Substance Use and HIVR25DA037190 · NIDA · MIRIAM HOSPITAL · PI CURT G BECKWITH · 2014 to 2026
$3.5M
Contextualized daily prediction of lapse risk in opioid use disorder by digital phenotypingR01DA047315 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI CURTIN, JOHN J., SHAH, DHAVAN · 2019 to 2023
$3.4M
Optimizing HIV care for patients with substance use disorders using predictive analytics in a mobile health applicationDP2DA042424 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI WESTERGAARD, RYAN PATRICK · 2016 to 2016
$2.3M
NIDA NIH HHS DP2 DA042424NIDA NIH HHS DP2DA042424NIDA NIH HHS R01 DA041063NIDA NIH HHS R01 DA047315NIDA NIH HHS R25 DA037190NIDA NIH HHS T32 DA037801NIDA NIH HHS T32DA037801
6 · The paper itself

Abstract

People living with HIV (PLWH) and substance use disorder (SUD) are particularly vulnerable to harmful health consequences of the global COVID-19 pandemic. The health and social consequences of the pandemic may exacerbate substance misuse and poor management of HIV among this population. This study compares substance use and HIV care before and during the pandemic using data collected weekly through an opioid relapse prevention and HIV management mobile-health intervention. We found that during the pandemic, PLWH and SUD have increased illicit substance use and contact with other substance-using individuals and decreased their confidence to stay sober and attend recovery meetings. The proportion of people missing their HIV medications also increased, and confidence to attend HIV follow-up appointments decreased. Optimal support for PLWH and SUD is critical during pandemics like COVID-19, as drug-related and HIV antiretroviral therapy (ART) non-adherence risks such as overdose, unsafe sexual behaviors, and transmission of infectious diseases may unfold.

Indexed as

TelemedicineAdultAnti-HIV AgentsCOVID-19Health Services AccessibilityHIV InfectionsHumansMaleMiddle AgedPandemicsSARS-CoV-2Substance-Related DisordersAnti-HIV AgentsCOVID-19HIVMobile-health interventionSubstance use disorder

Identifiers

PMID32705370
PMCPMC7376523
OpenAlexW3045358936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.